These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 1659747)
1. Heparin and low molecular weight heparin but not hirudin stimulate platelet aggregation in whole blood from acetylsalicylic acid treated healthy volunteers. Chen JH; Karlberg KE; Sylvén C Thromb Res; 1991 Aug; 63(3):319-29. PubMed ID: 1659747 [TBL] [Abstract][Full Text] [Related]
2. Heparin potentiation of collagen-induced platelet aggregation is related to the GPIIb/GPIIIa receptor and not to the GPIb receptor, as tested by whole blood aggregometry. Chen J; Sylvén C Thromb Res; 1992 May; 66(2-3):111-20. PubMed ID: 1329249 [TBL] [Abstract][Full Text] [Related]
3. Heparin enhances platelet aggregation irrespective of anticoagulation with citrate or with hirudin. Chen J; Karlberg KE; Sylvén C Thromb Res; 1992 Jul; 67(2):253-62. PubMed ID: 1440527 [TBL] [Abstract][Full Text] [Related]
4. Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin. Wallén NH; Ladjevardi M; Albert J; Bröijersén A Thromb Res; 1997 Jul; 87(1):151-7. PubMed ID: 9253810 [TBL] [Abstract][Full Text] [Related]
5. Future alternatives to heparin: low-molecular-weight heparin and hirudin. Donayre CE; Ouriel K; Rhee RY; Shortell CK J Vasc Surg; 1992 Apr; 15(4):675-82. PubMed ID: 1313932 [TBL] [Abstract][Full Text] [Related]
6. [Assessment of speed of an anti-platelet effect after two different doses of acetylsalicylic acid by flocculation]. Malý M; Vojácek J; Hadacová I; Mates M; Hájek P; Durdil V Vnitr Lek; 2004 Jun; 50(6):428-33. PubMed ID: 15346635 [TBL] [Abstract][Full Text] [Related]
7. Assessment of Multiplate platelet aggregometry using citrate, heparin or hirudin in Rhesus macaques. Dugan G; O'Donnell L; Hanbury DB; Cline JM; Caudell DL Platelets; 2015; 26(8):730-5. PubMed ID: 25549285 [TBL] [Abstract][Full Text] [Related]
8. [ON THE ISSUE OF SELECTION OF COAGULANTS UNDER ADP-INDUCED IMPEDANCE TEST OF AGGREGATION OF THROMBOCYTES IN PATIENTS WITH CHRONIC MYELO-PROLIFERATIVE TUMORS]. Stolyar MA; Ivashin DS; Olkhovsky IA Klin Lab Diagn; 2017 Mar; 62(3):156-60. PubMed ID: 30620525 [TBL] [Abstract][Full Text] [Related]
9. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Tóth O; Calatzis A; Penz S; Losonczy H; Siess W Thromb Haemost; 2006 Dec; 96(6):781-8. PubMed ID: 17139373 [TBL] [Abstract][Full Text] [Related]
10. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation. Badimon L; Badimon JJ; Lassila R; Heras M; Chesebro JH; Fuster V Blood; 1991 Jul; 78(2):423-34. PubMed ID: 2070078 [TBL] [Abstract][Full Text] [Related]
11. A method of testing platelet aggregation in native whole blood. Zwierzina WD; Kunz F Thromb Res; 1985 Apr; 38(1):91-100. PubMed ID: 3159126 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin. Jakubowski JA; Maraganore JM Blood; 1990 Jan; 75(2):399-406. PubMed ID: 2294999 [TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects. Klinkhardt U; Graff J; Westrup D; Kirchmaier CM; Esslinger HU; Breddin HK; Harder S Br J Clin Pharmacol; 2001 Sep; 52(3):297-305. PubMed ID: 11560562 [TBL] [Abstract][Full Text] [Related]
15. The effect of ex vivo anticoagulants on whole blood platelet aggregation. Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin. Storey RF; May JA; Heptinstall S Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of platelet aggregometry in dogs using the Multiplate platelet analyzer: impact of anticoagulant choice and assay duration. Marschner CB; Kristensen AT; Spodsberg EH; Wiinberg B J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):107-15. PubMed ID: 23016746 [TBL] [Abstract][Full Text] [Related]
18. Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin. Beumer S; IJsseldijk MJ; de Groot PG; Sixma JJ Blood; 1994 Dec; 84(11):3724-33. PubMed ID: 7949128 [TBL] [Abstract][Full Text] [Related]
19. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173 [TBL] [Abstract][Full Text] [Related]
20. Platelet aggregation, sensitivity to prostaglandin E1 and thromboxane A2 release in recombinant hirudin- and heparin-anticoagulated blood. Viigimaa M; Tsikas D; Frölich JC Blood Coagul Fibrinolysis; 1996 Mar; 7(2):259-61. PubMed ID: 8735834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]